Eli Lilly partners with Hims & Hers to expand access to obesity medicines

LLY•2026-11-06

Eli Lilly and Hims & Hers agreed to offer eligible patients home delivery of Lilly’s FDA-approved obesity medicines Zepbound and Foundayo through the Hims & Hers platform. Monthly self-pay prices start at $149 for Foundayo and $299 for Zepbound.

Eli Lilly partners with Hims & Hers to expand access to obesity medicines

1. Delivery and pricing

Related News

MKS Incorporated: Mizuho cuts target price to $290 from $330

Korro Bio to present at Jefferies Global Healthcare Conference

Senstar Technologies Q3 revenue $13.1 million

Sylvamo Corp Q3 net income from continuing operations was $85 million

Citigroup raises Unity Software target price to $59 from $48